Lyell Immunopharma Inc (LYEL)

Jul 23, 2025

What analysts say about Lyell Immunopharma Inc. stockLightning-fast capital gains - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

What drives Lyell Immunopharma Inc. stock priceFastest return on investment - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Positive week for Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional investors who lost 70% over the past year - simplywall.st

Jul 23, 2025

Jul 22, 2025

Is Lyell Immunopharma Inc. a good long term investmentFree Predictions - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Lyell Immunopharma's LYL314: A High-Risk, High-Reward Catalyst in the CAR T-Cell Space - AInvest

Jul 22, 2025

Jul 22, 2025

Lyell: 'Hold' Rating Based On Phase 3 LYL314 LBCL Treatment Program Advancement (LYEL) - Seeking Alpha

Jul 22, 2025

Jul 20, 2025

Lyell Immunopharma Inc. Stock Analysis and ForecastExceptional profit margins - PrintWeekIndia

Jul 20, 2025

Jul 20, 2025

Lyell Immunopharma registers 625,000 shares for resale - MSN

Jul 20, 2025

Jul 16, 2025

why lyell immunopharma inc. stock attracts strong analyst attentionStable Stocks With High Yield - Newser

Jul 16, 2025

Jul 16, 2025

Lyell Immunopharma (NASDAQ:LYEL) Stock Price Down 5.9% – What’s Next? - Defense World

Jul 16, 2025

Jul 15, 2025

Why Lyell Immunopharma Inc. stock attracts strong analyst attentionShort Term High Return Strategy - Newser

Jul 15, 2025

Jul 15, 2025

What makes Lyell Immunopharma Inc. stock price move sharplyPredictable High Return Trades - Newser

Jul 15, 2025

Jul 15, 2025

How Lyell Immunopharma Inc. stock performs during market volatilityFree Stock Market Trend Analysis - Newser

Jul 15, 2025

Jun 25, 2025

Lyell Immunopharma’s (LYEL) “Neutral” Rating Reiterated at HC Wainwright - Defense World

Jun 25, 2025

Jun 24, 2025

Lyell Immunopharma (NASDAQ:LYEL) Trading 3.5% Higher – What’s Next? - Defense World

Jun 24, 2025

Jun 23, 2025

Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewswire

Jun 23, 2025

Jun 18, 2025

Lyell reports new clinical data from trial of large B-cell lymphoma therapy - Yahoo Finance

Jun 18, 2025

Jun 17, 2025

Lyell’s lymphoma therapy shows high response rate in trial - Investing.com

Jun 17, 2025

Jun 17, 2025

Lyell’s lymphoma therapy shows high response rate in trial By Investing.com - Investing.com Nigeria

Jun 17, 2025

Jun 17, 2025

Lyell Immunopharma Announces Promising CAR T-Cell Trial Data - TipRanks

Jun 17, 2025

Jun 17, 2025

Lyell Immunopharma Says LYL314 Shows 'Robust' Responses in Large B-Cell Lymphoma Trial - marketscreener.com

Jun 17, 2025

Jun 17, 2025

Lyell Immunopharma (LYEL) Releases Promising Results from LYL314 Trial | LYEL Stock News - GuruFocus

Jun 17, 2025

Jun 17, 2025

Lyell Immunopharma Announces Positive Clinical Data From Phase 1/2 Trial Of Lyl314 For The Treatment Of Aggressive Large B-Cell Lymphoma - MarketScreener

Jun 17, 2025

Jun 17, 2025

Lyell Immunopharma Announces Positive New Clinical Data - GlobeNewswire

Jun 17, 2025

Jun 17, 2025

Lyell Immunopharma Stock Soars 23.11% Post Reverse Split - AInvest

Jun 17, 2025

Jun 10, 2025

Lyell Immunopharma (LYEL) Strengthens Leadership Team with Key A - GuruFocus

Jun 10, 2025

Jun 09, 2025

Lyell Immunopharma (LYEL) Announces Key Executive Appointments | LYEL Stock News - GuruFocus

Jun 09, 2025

Jun 09, 2025

Lyell Immunopharma Expands Board, Appoints New Director - TipRanks

Jun 09, 2025